Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ACCEGEN BIOTECH CORL311 Cell Line, ≥1.0 million/ frozen vial
Supplier: ACCEGEN BIOTECH ABCTC0183
Human lung small cell carcinoma. COR-L311 has been isolated from a 63 year-old male patient with extensive disease and relapse after 3 cycles of chemotherapy treatment with eroposide, colchicine, amethopterin and vincristine.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?